Further maintenance of remission for a year after infliximab withdrawal in ulcerative colitis treatment: a multicenter, controlled trial in Japan

Trial Profile

Further maintenance of remission for a year after infliximab withdrawal in ulcerative colitis treatment: a multicenter, controlled trial in Japan

Recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Infliximab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms HAYABUSA
  • Most Recent Events

    • 05 Mar 2014 Status changed from planning to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 08 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top